Cargando…

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients

BACKGROUND: In a cross-sectional analysis of cystic fibrosis (CF) patients with mild lung disease, reduced surfactant activity was correlated to increased neutrophilic airway inflammation, but not to lung function. So far, longitudinal measurements of surfactant function in CF patients are lacking a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griese, Matthias, Essl, Robert, Schmidt, Reinhold, Ballmann, Manfred, Paul, Karl, Rietschel, Ernst, Ratjen, Felix
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308867/ https://www.ncbi.nlm.nih.gov/pubmed/16274485 http://dx.doi.org/10.1186/1465-9921-6-133

Ejemplares similares

Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome
por: Griese, Matthias, et al.
Publicado: (2012)

Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
por: Dumas, Marie-Pier, et al.
Publicado: (2021)

L-Ornithine Derived Polyamines in Cystic Fibrosis Airways
por: Grasemann, Hartmut, et al.
Publicado: (2012)

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021)

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2014)

Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
por: Grasemann, Hartmut, et al.
Publicado: (2006)

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
por: Manali, Effrosyni D., et al.
Publicado: (2023)

The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease
por: Hector, Andreas, et al.
Publicado: (2011)

In Vitro Inhibition of Neutrophil Elastase Activity by Inhaled Anti-Pseudomonas Antibiotics Used in Cystic Fibrosis Patients
por: Hector, Andreas, et al.
Publicado: (2010)

Prognostic Relevance of Hypoglycemia Following an Oral Glucose Challenge for Cystic Fibrosis–Related Diabetes
por: Radike, Kerstin, et al.
Publicado: (2011)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Surfactant Lipidomics in Healthy Children and Childhood Interstitial Lung Disease
por: Griese, Matthias, et al.
Publicado: (2015)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Assessment of Surfactant Protein A (SP-A) dependent agglutination
por: Heinrich, Stefanie M, et al.
Publicado: (2010)

Quality of life is associated with physical activity and fitness in cystic fibrosis
por: Hebestreit, Helge, et al.
Publicado: (2014)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients – clinical analysis of Trichosporon positive patients in a Munich cohort
por: Kröner, Carolin, et al.
Publicado: (2013)

Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia
por: Stanke, Frauke, et al.
Publicado: (2010)

Novel Outcome Measures for Clinical Trials in Cystic Fibrosis
por: Tiddens, Harm AWM, et al.
Publicado: (2015)

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
por: Mouzaki, Marialena, et al.
Publicado: (2023)

Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus
por: Ballmann, Manfred, et al.
Publicado: (2014)

Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease
por: Griese, Matthias, et al.
Publicado: (2005)

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Papaioannou, Andriana I., et al.
Publicado: (2016)

Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
por: Junge, Sibylle, et al.
Publicado: (2016)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
por: Bradley, Judy M., et al.
Publicado: (2014)

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)

Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease
por: Tafel, Oliver, et al.
Publicado: (2008)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Human Cellular Models for the Investigation of Lung Inflammation and Mucus Production in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_se02q6u1f4u9l5jiejj2rem11i